Reduced corpus callosum white matter microstructural integrity revealed by diffusion tensor eigenvalues in abstinent methamphetamine addicts

NeuroToxicology

Volumn 30, Issue 2, 2009, Pages 209-213

  Kim, In Sung ^a   Kim, Yang Tae ^b   Song, Hui Jin ^a   Lee, Jae Jun ^a   Kwon, Do Hoon ^b   Lee, Hui Joong ^c   Kim, Myoung Nam ^a   Yoo, Done Sik ^d   Chang, Yongmin ^a,c  

^a Kyungpook National University   (South Korea)

^b Bugok National Hospital   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Electronics and Telecommunications Research Institute (ETRI)   (South Korea)

Author keywords

Corpus callosum; Diffusion tensor imaging; Methamphetamine; White matter

Indexed keywords

METHAMPHETAMINE;

ADULT; ANISOTROPY; ARTICLE; BRAIN SIZE; CELL STRUCTURE; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; WHITE MATTER; WISCONSIN CARD SORTING TEST; COMPARATIVE STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EFFECTS; METABOLISM; MYELINATED NERVE; PATHOLOGY; PROCEDURES; PSYCHOLOGIC TEST; PSYCHOLOGY;

ADULT; AMPHETAMINE-RELATED DISORDERS; CORPUS CALLOSUM; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MALE; METHAMPHETAMINE; NERVE FIBERS, MYELINATED; PSYCHOLOGICAL TESTS;

EID: 61849130129     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2008.12.002     Document Type: Article

References (39)

1. Alberson D.N., Pruetz B., Schmidt C.J., Khun D.M., Kapatos G., and Bannon M.J. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. Journal of Neurochemistry 88 (2004) 1211-1219
2. Ardekani B.A., Nierenberg J., Hoptman M.J., Javitt D.C., and Lim K.O. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport 14 (2003) 2025-2029
3. Axt K.J., Mamounas L.A., and Molliver M.E. Structural features amphetamine neurotoxicity in the brain. In: Cho A.K., and Segal D.S. (Eds). Amphetamine and its analogs: psychopharmacology, toxicology and abuse (1994), Academic, San Diego 315-367
4. Beaulieu C., Does M.D., Snyder R.E., and Allen P.S. Changes in water diffusion due to Wallerian degeneration in peripheral nerve. Magnetic Resonance in Medicine 36 (1996) 627-631
5. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR in Biomedicine 15 (2002) 435-455
6. Bhagat Y.A., and Beaulieu C. Diffusion anisotropy in subcortical white matter and cortical gray matter: changes with aging and the role of CSF-suppression. Journal of Magnetic Resonance Imaging 20 (2004) 216-227
7. Chung A., Lyoo I.K., Kim S.J., Hwang J., Bae S.C., Sung Y.H., et al. Decreased frontal white-matter integrity in abstinent methamphetamine abusers. The International Journal of Neuropsychopharmacology 10 (2007) 765-775
8. Commins D.L., and Seiden L.S. Alpha-methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex. Brain Research 365 (1986) 15-20
9. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Research Reviews 36 (2001) 1-22
10. Downhill J.E., Buchsbaum J., Wei M.S.T., Spiegel-Cohen J., Hazlett E.A., Haznedar M.M., et al. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophrenia Research 42 (2000) 193-208
11. Deng X., Wang Y., Chou J., and Cadet J.L. Methamphetamine causes wide spread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Research. Molecular Brain Research 93 (2001) 64-69
12. Ernst T., Chang L., Leonido-Yee M., and Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54 (2000) 1344-1349
13. Heaton R. Wisconsin Card Sorting Test Manual. Psychological Resources; 1993, Odessa, Florida.
14. Hommer D., Momenan R., Rawlings R., Ragan P., Williams W., Rio D., et al. Decreased corpus callosum size among alcoholic women. Archives of Neurology 53 (1996) 359-363
15. Jernigan T., Gamst A., Archibald S., Fennema-Notestine C., Mindt M., Marcotte T., et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. The American Journal of Psychiatry 162 (2005) 1461-1472
16. Kim J.M., Cho G.J., Hong S.K., Chang K.H., Chung J.S., Choi Y.H., et al. Epidemiology and clinical features of HIV infection/AIDS in Korea. Yonsei Medical Journal 44 (2003) 363-370
17. Kleven M.S., and Seiden L.S. Methamphetamine-induced neurotoxicity: structure activity relationships. Annals of the New York Academy of Sciences (1992) 654
18. Kokoshka J.M., Vaughan R.A., Hanson G.R., and Fleckenstein A.E. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. European Journal of Pharmacology 361 (1998) 269-275
19. Kubicki M., Westin C.-F., Maier S.E., Mamata H., Frumin M., and Ersner-Hershfield H. Diffusion tensor imaging and its application to neuropsychiatric disorders. Harvard Review of Psychiatry 10 (2002) 324-336
20. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Bramen J., et al. Regional cerebral dysfunction associated with mood disturbances in abstinent methamphetamine abusers. Archives of General Psychiatry 61 (2004) 73-84
21. 11C]WIN-35,428. The Journal of Neurosciences 18 (1998) 8417-8422
22. Melo P., Moreno V.Z., Vazquez S.P., Pinazo-Duran M.D., and Tavares M.A. Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine. Brain Research 1106 (2006) 21-29
23. Moeller F.G., Hasan K.M., Steinberg J.L., Kramer L.A., Dougherty D.M., Santos R.M., et al. Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology 30 (2005) 610-617
24. Moeller F.G., Steinberg J.L., Lane S.D., Buzby M., Swann A.C., Hasan K.M., et al. Diffusion tensor imaging in MDMA users and controls: association with decision making. American Journal of Drug and Alcohol Abuse 33 6 (2007) 777-789
25. Nordahl T., Salo R., and Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. The Journal of Neuropsychiatry and Clinical Neurosciences 15 (2003) 317-325
26. O'Callaghan J.P., and Miller D.B. Neurotoxic effects of substituted amphetamine in rats and mice: challenge to the current dogma. In: Massaro E., and Broderick P.A. (Eds). Handbook of neurotoxicity vol. 2 (2000), Humana Press, New York
27. Paulus M.P., Hozack N.E., Zauscher B.E., Frank L., Brown G.G., Braff D.L., et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26 (2002) 53-63
28. Pfefferbaum A., and Sullivan E.V. Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging. Neuropsychopharmacology 30 (2005) 423-432
29. Pierpaoli C., and Basser P.J. Toward a quantitative assessment of diffusion anisotropy. Magnetic Resonance in Medicine 36 (1996) 893-906
30. Pubill D., Canudas A.M., Pallas M., Camins A., Camarasa J., and Escubedo E. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Naunyn Schmiedeberg's Archives of Pharmacology 367 (2003) 490-499
31. Ricaurte G.A., Schuster C.R., and Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Research 193 (1980) 153-163
32. Rosenbloom M., Sullivan E.V., and Pfefferbaum A. Using magnetic resonance imaging and diffusion tensor imaging to assess brain damage in alcoholics. Alcohol Research & Health 27 (2003) 146-152
33. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry 158 (2001) 1206-1214
34. Sekine Y., Minabe Y., Ouchi Y., Takei N., Iyo M., Nakamura K., et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. American Journal of Psychiatry 160 (2003) 1699-1701
35. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., and Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage 17 (2002) 1429-1436
36. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Research. Brain Research Reviews 41 (2003) 203-228
37. Thomalla G., Glauche V., Koch M.A., Beaulieu C., Weiller C., and Rother J. Diffusion tensor imaging detects early Wallerian degeneration of the pyramidal tract after ischemic stroke. NeuroImage 22 (2004) 1767-1774
38. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., et al. Structural abnormalities in the brains of human subjects who use methamphetamine. The Journal of Neuroscience 24 (2004) 6028-6036
39. Volkow N.D., Chang L., Wang G.-J., Fowler J.S., Leonido-Yee M., Franceschi D., et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry 158 (2001) 377-382